Si deseas distinguir tus productos, servicios o ambos de los de otra empresa, es posible que necesites una marca o nombre comercial. Descubre qué son, en qué consiste su procedimiento de registro y qué implica.
Información sobre los plazos de presentación de solicitudes de transformación de marcas de la Unión Europea en marca nacional española. Más información
Si tienes un nuevo dispositivo, producto o procedimiento que resuelva un problema técnico o tenga una ventaja práctica, existen distintas formas de protegerlo en España y en otros países. Descubre cómo hacerlo.
¿Tu innovación reside en la estética, la ornamentación o la apariencia de tu producto? Protégela mediante un diseño industrial. Descubre qué derechos confiere el registro y cómo realizar la tramitación.
Las indicaciones geográficas protegen el nombre de un producto originario de una zona geográfica, a la cual le debe una determinada calidad, reputación u otra característica. Descubre qué son, en qué consiste su procedimiento de registro y qué beneficios conceden.
Las patentes publicadas en todo el mundo son una valiosa fuente de información científica, técnica y comercial.
Si eres emprendedor/a o una empresa y quieres potenciar y mejorar la rentabilidad de tu negocio protegiendo de forma adecuada los activos intangibles de tu organización, en este espacio encontrarás lo necesario.
402
resultados
Última actualización
27/08/2026 [09:07:00]
Resultados 350 a 375 de 402
Resumen de: KR20260117924A
0001a 본 발명의 일실시 형태는 발바닥의 아치 부분에 대응되는 발패드에 있어서,제1 물질로 3D 프린팅된 내부 패드, 및 상기 내부 패드를 감싸며, 제2 물질로 3D 프린팅된 외부 패드를 포함하는 발패드를 제공할 수 있다.
Resumen de: WO2026159076A1
Methods and systems for automatic generation of a crown shape for a dentition are described wherein the method comprises segmenting 3D maxillofacial data comprising the dentition, preferably by one or more trained deep neural networks, into a set of 3D dental objects; determining or receiving a position of a tooth, preferably based on a tooth classifier, in the dentition for which a target crown shape is to be determined; determining 3D spatial constraints for the target crown shape based on the set of 3D dental objects; determining an initial pose based for the target crown shape based on one or more 3D dental objects of the set of 3D dental objects; and, optimizing one or more optimization parameters associated with a digital crown shape model to determine the target crown shape, the optimizing including determining a trial crown shape using the digital crown shape model and the one or more optimization parameters, computing a loss value for the trial crown shape based on the 3D spatial constraints and the initial pose; and, if the loss value does not meet one or more optimization conditions modifying the one or more optimization parameters to determine a further trial crown shape and to compute a further loss value.
Resumen de: US20260215679A1
0000 Self-service optical stations having a form factor of a kiosk perform essential business transactions of a traditional optical store. A user takes eye tests and buys eyeglasses at the station without an attendant. The user may be sitting or standing in front of the station while conducting eye tests and business transactions. A telemedicine module communicates refraction results and patients in-take form to a refractionist at a remote location for review and approval. A virtual try-on module assists users to select matching frames to the user's face shape and lifestyle. A measurement module measures frame fitting parameters including pupil distance and the segment height while the user virtually wears a virtual frame. A point-of-sale module collects payment; a lab order module sends the purchase order to the fabrication facility where the lenses may be fabricated and assembled into the selected frames.
Resumen de: WO2026161540A1
A system for modeling organ-on-a-chip and other biological models includes a 3D-printed platform including a bioprinted vascular and interstitial infill capable of being seeded with active cells such that the functioning of organs (for example, human organs) may be replicated accurately. In particular, in vivo conditions may be replicated in a synthetic environment such that drug-induced vasculature injury (DIVI) may be simulated, studied and better understood.
Resumen de: US20260215832A1
Provided herein are methods, system, and devices for method of making one or more surgical guides and implants comprising: obtaining or having obtained one or more three-dimensional (3-D) image file(s) of an ankle, a foot, or both; generating a surgical plan and hardware dataset; using the surgical plan and hardware dataset to 3-D print or mill one or more surgical guides: opening(s) for inserting a bone screw(s) or pin(s); slots for drilling or cutting bone; slot(s) along an edge of the surgical guide(s) for aligning the surgical guide(s) for receiving a bone screw or pin; a surface that is contoured to match a surface of a target bone; indicia or predictive hole feature(s) for marking or aligning the surgical guide(s) to a bone or for marking a designation for the guide(s).
Resumen de: WO2026161556A1
A system for modeling organ-on-a-chip and other biological models includes a 3D- printed platform including a bioprinted vascular and interstitial infill capable of being seeded with active cells such that the functioning of organs (for example, human organs) may be replicated accurately. In particular, conditions may be replicated in a synthetic environment such that immune recruitment may be simulated, studied and better understood.
Resumen de: WO2026159645A1
A method, including obtaining data indicative of a response to electrical stimulation to tissue of a human, evaluating the obtained data and based on the evaluation, determining fitting settings for a tinnitus treatment device.
Resumen de: WO2026161200A1
A method is provided for generating and/or displaying a multimodal timelapse visualization. In some cases, the method can include identifying a plurality of records associated with a dental arch of a patient. Each record corresponds to a point in time and to an imaging modality of a plurality of imaging modalities. Based on processing of at least one record, a clinical finding is determined for the patient. A primary imaging modality is determined based at least in part on the clinical finding. At least a subset of the plurality of records is normalized. A timelapse visualization representing the normalized subset of records displayed in chronological order of the plurality of points in time is generated. The timelapse visualization is provided to a user device for presentation in a user interface of the user device.
Resumen de: WO2026156399A1
A multi-channel contact sensor measurement device (101x) provides physiological monitoring The device may include an attachment assembly configured to attach to a user's body. The device may include a sensor module contained within a housing that is configured to couple with the attachment assembly. The sensor module may include at least two sensors configured to generate respective sensor data when the device is attached to the user's body. The sensors may measure physiological parameters such as respiratory flow, respiratory rate, breath sounds, SpO₂, pulse rate, breathing effort, and/or chest movements. A central controller may process sensor data to derive biosignals from data related to the sensor measurements, which may allow for real-time analysis of sensor data and/or control of other medical devices. The modular design of the device optimizes usability and functionality across multiple modalities and applications. Other implementations are also described.
Resumen de: WO2026159723A1
A food product (402) includes cultured chicken cells selected from one cell type or plurality of cell types including chicken fibroblast cell, chicken myoblast cell, chicken adipocyte cell and biopolymer composition that supports structure and texture of cultured chicken cells, biopolymer composition includes blend of animal-based biopolymer, algal-based biopolymer, and plant-based biopolymer in form of biopolymer matrix The food product (402) is a bio- printed structure of biopolymer matrix and cultured chicken cells.
Resumen de: WO2026161553A1
A system for modeling organ-on-a-chip and other biological models includes a 3D- printed platform including a bioprinted vascular and interstitial infill capable of being seeded with active cells such that the functioning of organs (for example, human organs) may be replicated accurately. In particular, in vivo conditions may be replicated in a synthetic environment such that drug-induced liver injury (DILI) may be simulated, studied and better understood.
Resumen de: WO2026159195A1
The invention relates to a packaging tray (10) for medical devices (100), forming a 3D structure between a first plane and a second plane, and comprising: - a contour (2), extending in the first plane and being provided with peripheral walls (21) extending towards and/or as far as the second plane; - a first plate (3) extending in an intermediate plane arranged between the first plane and the second plane, and defining a plurality of openings (31) delimited by borders, the first plate being secured to the peripheral walls; - a second plate (4) extending in the second plane, and defining a plurality of abutments (41) arranged opposite the openings (31), the second plate being perforated over more than 40% of its surface; and - pillars (5) extending from the first plate to the second plate, so as to secure them locally.
Resumen de: US20260216431A1
0000 Disclosed herein is a system for administering a substance to a patient, the system comprising a reservoir for storing the substance, an administration apparatus configured to administer the substance to the patient, a pump for directing the substance from the reservoir to the delivery mechanism, a controller configured to operate the pump, a communication unit configured to communicate with at least one server, at least one processor configured to receive data associated with patient characteristics, calculate a substance administration dose according to the data, determine a preferred substance administration process, and operate the pump to administer the substance to the patient.
Resumen de: AU2025207025A1
A method of providing a personal drug injection system is disclosed. The method comprises determining at least one anthropometric characteristic from a person, and providing a plurality of types of personal drug injection systems. Each personal drug injection system of a personal drug injection system type is configured so as to fit with a part of the person's body that is intended to receive an injectable drug, and includes a drug injection location set that includes at least one defined drug injection location corresponding to a location of a drug injection site on the part of the person's body when the personal drug injection system is disposed on the part of the person's body. Each personal drug injection system type is associated with a defined range of anthropometric characteristics that is different to the defined range of anthropometric characteristics associated with the other personal drug injection system types, and each personal drug injection system type has an associated drug injection location set that is different to the drug injection location set of the other personal drug injection system types. The method also involves using the determined anthropometric characteristic and the defined ranges of anthropometric characteristics to select one of the personal drug injection system types from the plurality of personal drug injection system types already manufactured, and providing the person with the selected personal drug injection system type.
Resumen de: WO2026161466A1
A computer-implemented system identifies possible medical conditions based on pain location input on three-dimensional anatomical models. The system presents interactive 3D anatomical models with curved surface topology, enabling users to precisely indicate points of pain. A plurality of predefined training pain points, placed on the anatomical model by medical practitioners and associated with corresponding medical conditions, serve as reference data for condition matching. The system calculates spatial relationships between user-identified pain points and training pain points. Configurable exclusion zones, including axis-aligned regions and surface-conforming markers, enable practitioners to define anatomical boundaries that constrain which training pain points participate in the correlation analysis. The system generates possible conditions via spatial proximity and/or non-spatial factors such as reported pain intensity, pain duration, injury history, user demographic information, and responses to condition-specific questionnaires. The conditions are presented with associated clinical information such as history, findings, imaging recommendations, and treatment options.
Resumen de: WO2026161398A1
Systems and methods of a smart crash cart are disclosed herein. The smart crash cart may include a frame. The smart crash cart may include a plurality of drawers within the frame. The smart crash cart may include one or more radio signal sensors within the drawers. The one or more radio signal sensors may be configured to sense radio signals from one or more chips disposed on one or more items in the drawers. Each chip may contain information relating to an item of the one or more items. The information may include an expiration date of the item. The smart crash cart may include a display disposed on the frame configured to display a listing of one or more items in the plurality of drawers. The smart crash cart may include a battery electrically connected to at least the one or more radio signal sensors and the display.
Resumen de: US20260215883A1
The present application discloses a method for generating an edge cutting line for an orthodontic aligner, an orthodontic aligner, and a computer-readable medium in the field of orthodontic treatment. The generating method includes: identifying a tooth contour of a dental model corresponding to at least one first tooth, and obtaining a first region corresponding to the tooth contour; determining a second region corresponding to an attachment, wherein the attachment is located at least partially on the orthodontic aligner corresponding to at least a portion of the at least one first tooth or an interdental space, wherein the orthodontic aligner is related to the dental model; when the first region cannot completely cover the second region, generating an edge cutting line for the orthodontic aligner based on the second region, wherein the edge cutting line is configured to cut the orthodontic aligner.
Resumen de: WO2026157094A1
A degradable breast implant (100), which is a three-dimensional mesh structure and comprises a surface portion (110) and a filling portion (120). The surface portion (110) is a first three-dimensional virtual boundary (11) and is located on the periphery of the breast implant. The shape of the first three-dimensional virtual boundary (11) is a preset shape (210), and the size thereof is a preset size. A central position of the surface portion (110) is a base point (111). The surface portion (110) is filled with the filling portion (120). The filling portion (120) is a lattice structure formed by a plurality of lattice units (123). The fiber thickness of the lattice unit (123) is a wire diameter. The lattice structure comprises a plurality of interconnected and intercommunicating lattice layers (122). The shape of the lattice layer (122) is the same as the preset shape (210), and the size of the lattice layer (122) is proportionally reduced relative to the preset size. The wire diameters (d) of the same lattice layer (122) are identical, and the wire diameters (d) of different lattice layers (122) gradually decrease in a direction from the base point (111) towards the surface portion (110). By designing the wire diameters (d) of different lattice layers (122) to gradually decrease in the direction from the base point (111) towards the surface portion (110), the problem of uneven regeneration and growth of breast tissue caused by no difference in the degradation rate of the bre
Resumen de: WO2025015047A1
In an aspect, a wearable device for targeted peripheral stimulation is presented. The wearable device includes a sensor configured to receive data and generate sensor output. The wearable device includes a processor in communication with the sensor. The wearable device includes a memory communicatively connected to the processor. The memory contains instructions configuring the processor to receive the sensor output from the sensor, the sensor output indicative of one or more movement disorder symptoms of a user. The processor is configured to determine a disease state of the one or more movement disorder symptoms. The processor is configured to generate a stimulation output based on the one or more movement disorder symptoms and the disease state of the movement disorder symptoms.
Resumen de: EP4782044A1
Herein is discussed a medical device comprising a marker (100) for marking a marker position of the medical device, the medical device comprising: a tube of the medical device; a radiopaque marking material (100) to mark the marker position of the medical device; and wherein the radiopaque marking material (100) is added by additive manufacturing in fluid from at the marker position of the medical device on the tube forming a solid radiopaque marker (100) for increasing an X-ray opacity of the medical device in a radial direction (R). In particular, the tube can comprise fibers of a braided and/or coiled wire mesh (210) and the method comprises the step of fixing with the marking material fibers of the braided and/or coiled wire mesh (210).
Resumen de: DE202019006263U1
Sensorsteuervorrichtung (302), aufweisend:- ein Elektronikgehäuse (304), enthaltend:-- eine Hülle (306) und eine Halterung (308), die während eines werkseitigen Zusammenbaus an der Hülle (306) befestigt wird, um ein Inneres des Elektronikgehäuses (304) zu definieren;-- einen oder mehrere Flansche (12012, 12112) auf einer inneren Oberfläche der Halterung (308), wobei sich der eine oder die mehreren Flansche (12012, 12112) in das Innere des Elektronikgehäuses (304) erstrecken;- einen Analytsensor (11900), der einen distalen Abschnitt, der sich von dem Elektronikgehäuse (304) erstreckt und ausgebildet ist, einen Analytwert zu messen, und einen proximalen Abschnitt innerhalb des Inneren des Elektronikgehäuses (304) aufweist, der eine Vielzahl von Sensorkontakten (11914) enthält;- eine Leiterplatte (502), die innerhalb des Inneren des Elektronikgehäuses (304) angeordnet ist; und- eine Verbindungselementanordnung (12000, 12100) innerhalb des Inneren des Elektronikgehäuses (304), aufweisend:-- eine Vielzahl von Elementen (12004, 12104), die ausgebildet sind, die leitfähige Kommunikation zwischen der Vielzahl von Sensorkontakten (11914) des Analytsensors (11900) und der Leiterplatte (502) bereitzustellen; und-- ein Verbindungselement (12002, 12102), das eine erste Seite gegenüberliegend einer zweiten Seite aufweist, wobei die erste Seite aufweist:--- eine Vielzahl von Aussparungen (12008, 12108), die ausgebildet sind, die Vielzahl von Elementen (12004, 12104) aufzunehme
Resumen de: EP4781904A2
The invention discloses a wearable electronic device and a method for measuring biological information. The device comprises a first sensor; a second sensor; communication circuitry; at least one processor; and memory storing instructions that, when executed by the at least one processor, cause the wearable electronic device to: receive, via the first sensor, information relating to a movement of the wearable electronic device, receive, via the second sensor, a biological signal for a user wearing the wearable electronic device, responsive to the movement of the wearable electronic device being less than a predetermined threshold during a first time period, identify a resting pulse rate of the user based on the biological signal which is received, responsive to the movement of the wearable electronic device being greater than the predetermined threshold during a second time period, exclude biological signals during the second time period from identifying the resting pulse rate of the user, and transmit, through the communication circuitry, information regarding the resting pulse rate of the user to an external electronic device connected with the wearable electronic device, so that the external electronic device displays information regarding the resting pulse rate of the user.
Resumen de: EP4781909A1
0001 Systems and methods described provide dynamic and intelligent ways to change the required level of user interaction during use of a monitoring device. The systems and methods generally relate to real time switching between a first or initial mode of user interaction and a second or new mode of user interaction. In some cases, the switching will be automatic and transparent to the user, and in other cases user notification may occur. The mode switching generally affects the user's interaction with the device, and not just internal processing. The mode switching may relate to calibration modes, data transmission modes, control modes, or the like.
Resumen de: JP2026123223A
0001 Problem To provide a technology for verifying the configuration of a drug delivery device based on data received from a communication tag placed on the drug delivery device. Solution A drug delivery device 102 having a housing with a reservoir large enough to hold a drug, an activation button to start injecting the drug, and a label attached to at least a portion of the housing, wherein the label includes a communication tag that, when accessed by a mobile device 106, causes the mobile device to launch a web browser to access a uniform resource locator (URL) 132. The mobile device receives data from the communication tag placed on the drug delivery device and, based on the received data, verifies and/or authenticates the configuration of the drug delivery device or tracks ownership of the drug delivery device. Selected Figure Figure 5
Nº publicación: KR20260117838A 29/07/2026
Solicitante:
RAI STRATEGIC HOLDINGS INC [US]
\uB808\uC774 \uC2A4\uD2B8\uB77C\uD2F0\uC9C1 \uD640\uB529\uC2A4, \uC778\uD06C.
Resumen de: CA3160182A1
0001 A security tag can prohibit unauthorized usage of a device or product. The device may include an electronic nicotine delivery systems ("ENDS") device, which may include aerosol delivery devices such as smoking articles that produce aerosol. The security tag can prevent usage until authorized. Attempts at usage without authorization can result in the device being unusable. The authorization may include identity confirmation or age verification.
BOPI
Sede Electrónica
